Neurology is the class of medicine that deals with the nervous system. One in six people is affected by brain or nervous system diseases: more than 50 million people have epilepsy; almost 47 million are affected by dementia globally. Therefore, the global market for neurological drugs is massive. CD BioSciences brings a depth of knowledge to your study based on experience across a range of neurologic disorders. Our clinical trial experience with neurology makes us to work with you at any stage of drug development from Phase I through Phase IV for traditional as well as highly innovative clinical targets.
Our unparalleled research experience in neurological disorders allows us not only to understand the complexities associated with neurological disorders clinical trial design, but also to operationally implement specific design features through the employ of innovative strategies and tools that mitigate risks and challenges inherent in this type of study. Common neurological disorders include Alzheimer’s disease (AD), epilepsy, migraines, stoke, Parkinson disease, and Multiple sclerosis (MS), as well as neurological problems caused by other disorders, such as cerebrovascular disease and infections.
Therapeutic Solutions Relied on Expertise
At CD BioSciences, we offer high quality clinical data management to support your drug development needs to get drugs to market as quickly as possible so patients have access to drugs. From the complete Investigational New Drug (IND) support program, early preclinical drug development to clinical and commercial manufacture and release, we provide a wide range of standards and specialized laboratory services to complement and enhance drug development programs at every stage. We provide bespoke solutions tailored to your requirements and provide real time, faster access to data meaning faster decisions can be made to keep patients as safe as possible. Thanks to our experienced professionals, we provide small molecule, DNA/RNA, gene therapy, biologics, and cellular therapy as therapeutic solutions for clients.
End-to-end Phase I–IV Package
CD BioSciences provides end to end comprehensive clinical data management services from Phase I through to post-marketing trials. Our team of global clinical data management experts are availabed to upholding a standardized, process-driven approach. From research design, lead optimization to product launch, commercialization, CD BioSciences has the expertise and the only resources you need to help manage molecular complexity and help you realize the full potential of your program. Explore each stage of our clinical services includes bioanalytical lab testing, clinical pharmacology, proof of concept, early phase trials, phase IIa trials, phase IIb trials, and clinical data management analysis and reporting, are shown in the right side.
The goal of CD BioSciences is to help drug developers take assets from the post-discovery into the clinic and strategize pathways to accelerate the drug development to market. Unlike traditional clinical research organizations (CRO), CD BioSciences has the expertise to deliver standalone consulting services for early clinical development or as part of our full service, end-to-end clinical trial solutions. Our team is nimble, flexible and composed of seasoned clinical scientists and subject matter experts with expertise across science, medicine, regulatory affairs, clinical development and clinical operations. For further details, please don't hesitate to contact us.